Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-018358
Filing Date
2021-05-05
Accepted
2021-05-05 16:31:37
Documents
1
Period of Report
2021-05-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7812
  Complete submission text file 0000899243-21-018358.txt   9312
Mailing Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O BLACK DIAMOND THERAPEUTICS, INC. 139 MAIN STREET CAMBRIDGE MA 02142
Business Address
Roberts Christopher D. (Reporting) CIK: 0001788368 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39200 | Film No.: 21893891